EssilorLuxottica Announces Acquisition of Health Technology Company RetinAI
Published on October 16, 2025
PARIS—EssilorLuxottica (Reuters: ESLX.PA) announced yesterday that it has acquired Ikerian AG, a health technology company operating under the RetinAI brand, which specializes in artificial intelligence (AI) and data management in the eyecare sector. In making the announcement, the company advised that the move reinforces its “med-tech journey,” adding into its portfolio advanced software powered by machine learning and computer vision, with the goal of further offering solutions that streamline clinical, research and pharmaceutical workflows and deliver actionable AI-driven insights.